investors
News/ News/ Sales and Marketing
Second hedge fund applies pressure on GSK after taking stake
Phil Taylor
Bluebell Capital Partners, Elliott Management, Emma Walmsley, GlaxoSmithKline, investors, senior management
0 Comment
X
Second hedge fund applies pressure on GSK after taking stake
https://pharmaphorum.com/news/second-hedge-fund-applies-pressure-on-gsk-after-taking-stake/
Market Access/ News/ News/ News/ Oncology
Celgene investors’ CVR payment looks rocky, as FDA rejects ide-cel file
Phil Taylor
Bristol-Myers Squibb, Celgene, Financial, investors, Mergers and acquisitions
0 Comment
X
Celgene investors’ CVR payment looks rocky, as FDA rejects ide-cel file
https://pharmaphorum.com/news/celgene-investors-merger-payment-looks-rocky-as-fda-rejects-ide-cel-file/
Warren Buffet shocks Wall Street with Biogen gamble
Richard Staines
aducanumab, Alzheimer's, Biogen, investors, neurology, R&D, Teva
0 Comment
X
Warren Buffet shocks Wall Street with Biogen gamble
https://pharmaphorum.com/news/warren-buffet-shocks-wall-street-with-biogen-gamble/